Skip to main content

Advertisement

Log in

Clinical Studies

Incidence of inguinofemoral lymph node metastases at the first local recurrence of vulvar cancer: a Dutch nationwide study

  • Article
  • Published:
British Journal of Cancer Submit manuscript

Abstract

Background

Up to 40% of vulvar cancer patients present with local recurrence within 10 years of follow-up. An inguinofemoral lymphadenectomy (IFL) is indicated if not performed at primary treatment. The incidence and risk factors for lymph node metastases (LNM) at first local recurrence, however, are unclear. Our aim was to determine the incidence of LNM at first local recurrence, in relation to previous groin treatment and clinicopathological factors.

Methods

A multicenter cohort study including vulvar cancer patients with a first macroinvasive local recurrence after primary surgical treatment between 2000 and 2015 was conducted in the Netherlands. Groin status at local recurrence was defined as positive (N+), negative (N−) or unknown (N?) and based on histology, imaging and follow-up. Patient-, tumour- and treatment characteristics of primary and recurrent disease were analysed.

Results

Overall, 16.3% (66/404) had a N+ groin status at first local recurrence, 66.4% (268/404) N− and 17.3% (70/404) N? groin status. The incidence of a N+ groin status was comparable after previous SLN and IFL, 11.5% and 13.8%, respectively. A N+ groin status was related to tumour size (25 vs.12 mm; P < 0.001), depth of invasion (5 vs. 3 mm; P < 0.001) and poorly differentiated tumours (22.9 vs. 11.9%; P = 0.050) at local recurrence.

Conclusions

The incidence of LNM at first local recurrence in vulvar cancer patients was 16.3%, and independent of previous type of groin surgery. In accordance with primary diagnosis, tumour size, depth of invasion, and tumour grade were significantly associated with a positive groin status.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2: Groin status at first local recurrence of vulvar cancer (N = 404).
Fig. 3: Positive groin status at local recurrence in relation to type of groin surgery at primary treatment (n = 66).
Fig. 4: Positive groin status at local recurrence in patients with SLN procedure at primary treatment (n = 187).
Fig. 5: Positive groin status at recurrence in patients with previous IFL (n = 136).
Fig. 6: Time to first local recurrence of vulvar cancer.

Similar content being viewed by others

Data availability

All data generated or analysed during this study are included in this published article (and its supplementary information files).

References

  1. Institute NC SEER cancer statistics factsheets: vulvar cancer. 2020. https://seer.cancer.gov/statfacts/html/vulva.html.

  2. Schuurman M, van den Einden L, Massuger L, Kiemeney L, van der Aa M, de Hullu J. Trends in incidence and survival of Dutch women with vulvar squamous cell carcinoma. Eur J Cancer. 2013;49:3872–80.

    Article  CAS  PubMed  Google Scholar 

  3. Pleunis N, Schuurman MS, Van Rossum MM, Bulten J, Massuger LF, De Hullu JA, et al. Rare vulvar malignancies; incidence, treatment and survival in the Netherlands. Gynecol Oncol. 2016;142:440–5.

    Article  CAS  PubMed  Google Scholar 

  4. van der Steen S, de Nieuwenhof HP, Massuger L, Bulten J, de Hullu JA. New FIGO staging system of vulvar cancer indeed provides a better reflection of prognosis. Gynecol Oncol. 2010;119:520–5.

    Article  PubMed  Google Scholar 

  5. Oonk MH, Hemel BMV, Hollema H, Hullu JAD, Ansink AC, Vergote I, et al. Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study. Lancet Oncol. 2010;11:646–52.

    Article  PubMed  Google Scholar 

  6. Zhou J, Shan G. The prognostic role of FIGO stage in patients with vulvar cancer: a systematic review and meta-analysis. Curr Med Res Opin. 2016;32:1121–30.

    Article  CAS  PubMed  Google Scholar 

  7. De Hullu JA, Hollema H, Lolkema S, Boezen M, Boonstra H, Burger MP, et al. Vulvar carcinoma. The price of less radical surgery. Cancer. 2002;95:2331–8.

    Article  PubMed  Google Scholar 

  8. Van der Zee AG, Oonk MH, De Hullu JA, Ansink AC, Vergote I, Verheijen RH, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol. 2008;26:884–9.

    Article  PubMed  Google Scholar 

  9. Hacker NF, Leuchter RS, Berek JS, Castaldo TW, Lagasse LD. Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisions. Obstet Gynecol. 1981;58:574–9.

    CAS  PubMed  Google Scholar 

  10. Oonk M, Planchamp F, Baldwin P, Bidzinski M, Brännström M, Landoni F, et al. European Society of Gynaecological Oncology Guidelines for the management of patients with vulvar cancer. Int J Gynecol Cancer. 2017;27:832–7.

    Article  PubMed  Google Scholar 

  11. Gaarenstroom KN, Kenter GG, Trimbos JB, Agous I, Amant F, Peters AA, et al. Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions. Int J Gynecol Cancer. 2003;13:522–7.

    Article  CAS  PubMed  Google Scholar 

  12. Leermakers ME, Pleunis N, Boll D, Hermans RH, Ezendam NP, Pijnenborg JM. High incidence of erysipelas after surgical treatment for vulvar carcinoma: an observational study. Int J Gynecol Cancer. 2016;26:582–7.

    Article  PubMed  Google Scholar 

  13. Woolderink JM, de Bock GH, de Hullu JA, Davy MJ, van der Zee AG, Mourits MJ. Patterns and frequency of recurrences of squamous cell carcinoma of the vulva. Gynecol Oncol. 2006;103:293–9.

    Article  PubMed  Google Scholar 

  14. Te Grootenhuis NC, van der Zee AG, van Doorn HC, van der Velden J, Vergote I, Zanagnolo V, et al. Sentinel nodes in vulvar cancer: long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I. Gynecol Oncol. 2016;140:8–14.

    Article  Google Scholar 

  15. Pouwer AW, Arts HJ, van der Velden J, de Hullu JA. Limiting the morbidity of inguinofemoral lymphadenectomy in vulvar cancer patients; a review. Expert Rev Anticancer Ther. 2017;17:615–24.

    Article  CAS  PubMed  Google Scholar 

  16. van Doorn HC, Oonk MHM, Fons G, Gaarenstroom KN, de Hullu J, van Rosmalen J, et al. Sentinel lymph node procedure in patients with recurrent vulvar squamous cell carcinoma: a proposed protocol for a multicentre observational study. BMC Cancer. 2022;22:445.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Nikolić O, Sousa FAE, Cunha TM, Nikolić MB, Otero-García MM, Gui B, et al. Vulvar cancer staging: guidelines of the European Society of Urogenital Radiology (ESUR). Insights Imaging. 2021;12:131.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Land RHJ, Moskovic E, King M, Sohaib SA, Trott P, et al. Routine computerized tomography scanning, groin ultrasound with or without fine needle aspiration cytology in the surgical management of primary squamous cell carcinoma of the vulva. Int J Gynecol Cancer. 2006;16:312–7.

    Article  CAS  PubMed  Google Scholar 

  19. Woelber L, Eulenburg C, Kosse J, Neuser P, Heiss C, Hantschmann P, et al. Predicting the course of disease in recurrent vulvar cancer—a subset analysis of the AGO-CaRE-1 study. Gynecol Oncol. 2019;154:571–6.

    Article  PubMed  Google Scholar 

  20. Nooij LS, van der Slot MA, Dekkers OM, Stijnen T, Gaarenstroom KN, Creutzberg CL, et al. Tumour-free margins in vulvar squamous cell carcinoma: Does distance really matter? Eur J Cancer. 2016;65:139–49.

    Article  CAS  PubMed  Google Scholar 

  21. Yap JK, Fox R, Leonard S, Ganesan R, Kehoe ST, Dawson CW, et al. Adjacent lichen sclerosis predicts local recurrence and second field tumour in women with vulvar squamous cell carcinoma. Gynecol Oncol. 2016;142:420–6.

    Article  CAS  PubMed  Google Scholar 

  22. Tantipalakorn C, Robertson G, Marsden DE, Gebski V, Hacker NF. Outcome and patterns of recurrence for International Federation of Gynecology and Obstetrics (FIGO) stages I and II squamous cell vulvar cancer. Obstet Gynecol. 2009;113:895–901.

    Article  PubMed  Google Scholar 

  23. Te Grootenhuis NC, Pouwer AW, de Bock GH, Hollema H, Bulten J, van der Zee AGJ, et al. Prognostic factors for local recurrence of squamous cell carcinoma of the vulva: a systematic review. Gynecol Oncol. 2018;148:622–31.

    Article  Google Scholar 

  24. (WOG) WOG. National Guideline vulvar carcinoma. 2018. https://www.oncoline.nl/vulvacarcinoom2011.

  25. Maaskant-Braat AJ, Voogd AC, Roumen RM, Nieuwenhuijzen GA. Repeat sentinel node biopsy in patients with locally recurrent breast cancer: a systematic review and meta-analysis of the literature. Breast Cancer Res Treat. 2013;138:13–20.

    Article  PubMed  Google Scholar 

  26. Beasley GM, Speicher P, Sharma K, Seigler H, Salama A, Mosca P, et al. Efficacy of repeat sentinel lymph node biopsy in patients who develop recurrent melanoma. J Am Coll Surg. 2014;218:686–92.

    Article  PubMed  Google Scholar 

  27. van Doorn HC, van Beekhuizen HJ, Gaarenstroom KN, van der Velden J, van der Zee AG, Oonk MH, et al. Repeat sentinel lymph node procedure in patients with recurrent vulvar squamous cell carcinoma is feasible. Gynecol Oncol. 2016;140:415–9.

    Article  PubMed  Google Scholar 

  28. Oonk MHM, Slomovitz B, Baldwin PJW, van Doorn HC, van der Velden J, de Hullu JA, et al. Radiotherapy versus inguinofemoral lymphadenectomy as treatment for vulvar cancer patients with micrometastases in the sentinel node: results of GROINSS-V II. J Clin Oncol. 2021;39:3623–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Pounds R, O'Neill D, Subba K, Garg A, Scerif M, Leong E, et al. The role of preoperative computerized tomography (CT) scan of the pelvis and groin in the management of clinically early staged vulva squamous cell carcinoma. Gynecol Oncol. 2020;157:444–9.

    Article  PubMed  Google Scholar 

  30. Pleunis N, Pouwer A, van Heertum A, te Grootenhuis N, Massuger L, Tjiong M, et al. EP1180 Incidence and prognostic factors for inguinofemoral lymph node metastasis in patients with a first local recurrence of vulvar squamous cell carcinoma. Int J Gynecol Cancer. 2019;29:A609.

    Google Scholar 

Download references

Acknowledgements

Published conference abstracts: in an earlier stage of the study, the abstract was presented at the European Society of Gynecological Oncology (ESGO) meeting in 2019 [30]. Additional contributions: Martijn Mensink, Anouk van Heertum and Anne Hompesch are medical (Master of Science) students and were involved in the data collection process as part of their thesis.

Funding

The author(s) received no specific funding for this work.

Author information

Authors and Affiliations

Authors

Contributions

Conceptualisation: JdH, HP, NP and AFP. Data curation: NP, AFP, MO, HvD, MT, JvdV, HZ, MvP, EvD and BS. Formal Analysis: NP, JdH and HP. Methodology: NP, AFP, JdH and HP. Supervision: JdH and HP. Writing—original draft: NP. Writing—review and editing: NP, AFP, MO, HvD, MT, JvdV, HZ, MvP, EvD, BS and CV.

Corresponding author

Correspondence to Noortje Pleunis.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval and consent to participate

The study was approved by the medical ethics committee at the Radboud University Medical Center (case file number 2017–3475) and all local ethics committees. All required data had been previously registered during medical treatment and records were anonymized. The study was performed in accordance with the Declaration of Helsinki.

Consent for publication

Not applicable.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Supplement 1; Localization of primary tumor in relation to first local recurrence (n = 338)

41416_2023_2373_MOESM2_ESM.docx

Supplement 2; Exploration of reasons for refraining from surgical treatment in patients with N+ groin status at local recurrence on basis of positive imaging (n = 10)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pleunis, N., Pouwer, AF.W., Oonk, M.H.M. et al. Incidence of inguinofemoral lymph node metastases at the first local recurrence of vulvar cancer: a Dutch nationwide study. Br J Cancer 129, 956–964 (2023). https://doi.org/10.1038/s41416-023-02373-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41416-023-02373-0

  • Springer Nature Limited

Navigation